Visiongain publishes Allergic Rhinitis Drugs Market 2020-2030 report

Forecasts by Sub-Markets (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others), Intranasal Antihistamines (Dymista, Generic Intranasal Azelastine, Astepro, Patanase, Astelin, Others), Intranasal Corticosteroids (Flixonase/Flonase/Flonase OTC, Nasonex, Avamys/Veramyst, Rhinocort, Nasacort/Nasacort-OTC, Omnaris, Beconase/Beconaes AQ, Qnasl, Zetonna, Others), Oral Antihistamines (Allegra/Allegra-D/Allegra OTC, Claritin/Claritin OTC, Zyrtec/Zyrtec D, Xyzal, Clarinex, Allelock, Ebastel, Talion, Others), Immunotherapy and Vaccines (Staloral, Alutard SQ, Grazax/Grastek, Oralair, Ragwitek, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA)

News provided by

Visiongain

Aug 28, 2020, 04:00 ET

LONDON, Aug. 28, 2020 /PRNewswire/ -- Allergic Rhinitis Drugs–our new study reveals trends, R&D progress, and predicted revenues
Where is the Allergic Rhinitis Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 330+ page report provides 450+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Allergic Rhinitis Drugs Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, SWOT, and Porter's Fiver Forces Analysis), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email [email protected]

To request sample pages from this report please email [email protected] or refer to our website: https://www.visiongain.com/report/allergic-rhinitis-drugs-market-report-2020-2030/#download_sampe_div

Discover sales predictions for the world market and submarkets

Global Allergic Rhinitis Drugs Market by Sub-Markets

• Intranasal Antihistamines
• Dymista
• Generic Intranasal Azelastine
• Astepro
• Patanase
• Astelin
• Others

• Intranasal Corticosteroids
• Flixonase/Flonase/Flonase OTC
• Nasonex
• Avamys/Veramyst
• Rhinocort
• Nasacort/Nasacort-OTC
• Omnaris
• Beconase/Beconaes AQ
• Qnasl
• Zetonna
• Others

• Oral Antihistamines
• Allegra/Allegra-D/Allegra OTC
• Claritin/Claritin OTC
• Zyrtec/Zyrtec D
• Xyzal, Clarinex
• Allelock
• Ebastel
• Talion
• Others

• Immunotherapy and Vaccines
• Staloral
• Alutard SQ
• Grazax/Grastek
• Oralair
• Ragwitek
• Others

• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Belgium
• Switzerland
• Rest of Europe

Asia-Pacific
• Japan
• China
• India
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East and Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Allergic Rhinitis Drugs Market, with a focus on this segment of these companies' operations. There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth

Overall world revenue for Allergic Rhinitis Drugs Market will surpass $xyz billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Allergic Rhinitis Drugs Market report helps you

In summary, our 330+ page report provides you with the following knowledge:

• Revenue forecasts to 2030 for Allergic Rhinitis Drugs Market, with forecasts for Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others, each forecasted at a global and regional level– discover the industry's prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Allergic Rhinitis Drugs market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, UAE, Saudi Arabia, and South Africa.

• Prospects for established firms and those seeking to enter the market– including company profiles for Merck KGaA, Stallergenes Greer, AstraZeneca, Boehringer Ingelheim International GmbH, Bayer AG, Novartis AG, GSK, Johnson & Johnson, UCB S.A., Kyowa Hakko Kirin, ALK-Abelló A/S, and Sanofi involved in the Allergic Rhinitis Drugs Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To request a report overview of this report please email [email protected] or refer to our website: https://www.visiongain.com/report/allergic-rhinitis-drugs-market-report-2020-2030/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

ALK-Abelló A/S
AstraZeneca
Bayer AG\
Boehringer Ingelheim International GmbH
GSK
Johnson & Johnson
Kyowa Hakko Kirin
Merck KGaA
Novartis AG
Sanofi
Stallergenes Greer
UCB S.A.

Organizations

American Academy of Allergy, Asthma and Immunology (AAAAI)
British Society for Allergy & Clinical Immunology (BSACI) [UK]
International Nurses Group In Immunodeficiencies
Japanese Ministry of Health, Labour and Welfare
Les Entreprises Du Médicament (Leem) [France]
National Development and Reform Commission (NDRC) [China]
National Pharmaceutical Pricing Authority (NPPA) [India]
PollenUK
The Pharmaceutical Research and Manufacturers of America (PhRMA)
The UK Health and Social Care Information Centre
US Food and Drug Administration (FDA)
World Allergy Organisation
World Health Organisation (WHO)

To see a report overview please e-mail [email protected]

Top 26 Asthma & COPD Companies 2020-2030

Global Asthma & COPD Therapies Market 2019-2029

Novel Coronavirus (COVID-19) Drugs in Development Market Forecast 2020-2030

SOURCE Visiongain